MFDS
- Marketing authorisation holder: UIHC PET IMAGING
- Status: likely_approved
🇰🇷 Ga-68-DOTATOC in South Korea
Ga-68-DOTATOC (EDOTREOTIDE) regulatory status in South Korea.
Marketing authorisation
Ga-68-DOTATOC in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Oncology approved in South Korea
Frequently asked questions
Is Ga-68-DOTATOC approved in South Korea?
Yes. MFDS has authorised it.
Who is the marketing authorisation holder for Ga-68-DOTATOC in South Korea?
UIHC PET IMAGING holds the South Korean marketing authorisation.